Cargando…
WNT9A Is a Conserved Regulator of Hematopoietic Stem and Progenitor Cell Development
Hematopoietic stem cells (HSCs) differentiate into all cell types of the blood and can be used therapeutically to treat hematopoietic cancers and disorders. Despite decades of research, it is not yet possible to derive therapy-grade HSCs from pluripotent precursors. Analysis of HSC development in mo...
Autores principales: | Richter, Jenna, Stanley, Edouard G., Ng, Elizabeth S., Elefanty, Andrew G., Traver, David, Willert, Karl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852562/ https://www.ncbi.nlm.nih.gov/pubmed/29382179 http://dx.doi.org/10.3390/genes9020066 |
Ejemplares similares
-
Protocol for the Generation of Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
por: Nafria, Monica, et al.
Publicado: (2020) -
Wnt9a Is Required for the Aortic Amplification of Nascent Hematopoietic Stem Cells
por: Grainger, Stephanie, et al.
Publicado: (2016) -
WNT3A Promotes Hematopoietic or Mesenchymal Differentiation from hESCs Depending on the Time of Exposure
por: Gertow, Karin, et al.
Publicado: (2013) -
EGFR is required for Wnt9a/Fzd9b signalling specificity in haematopoietic stem cells
por: Grainger, Stephanie, et al.
Publicado: (2019) -
Generation of Megakaryocytic Progenitors from Human Embryonic Stem Cells in a Feeder- and Serum-Free Medium
por: Pick, Marjorie, et al.
Publicado: (2013)